| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000025924 |
| Receipt No. | R000029808 |
| Official scientific title of the study | Study of beneficial effects of citrus juice fermented with lactic acid bacteria on the symptoms of Japanese cedar pollinosis; a randomized, double-blind, placebo-controlled trial |
| Date of disclosure of the study information | 2017/01/31 |
| Last modified on | 2018/03/02 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study of beneficial effects of citrus juice fermented with lactic acid bacteria on the symptoms of Japanese cedar pollinosis; a randomized, double-blind, placebo-controlled trial | |
| Title of the study (Brief title) | Study of beneficial effects of citrus juice fermented with lactic acid bacteria on the symptoms of Japanese cedar pollinosis | |
| Region |
|
|
| Condition | ||
| Condition | Japanese cedar pollinosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To evaluate effects of citrus juice fermented with lactic acid bacteria on attenuation of the symptoms of Japanese cedar pollinosis in a randomized, double-blind, placebo-controlled trial. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The symptoms of Japanese cedar pollinosis after starting consumption of test beverage |
| Key secondary outcomes | Results of blood test / Quality of life(QOL) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Taking 125ml of citrus juice fermented with lactic acid bacteria every day for 8 weeks during pollen scattering season. | |
| Interventions/Control_2 | Taking 125ml of unfermented citrus juice (placebo) every day for 8 weeks during pollen scattering season. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The subjects who experienced the symptoms of Japanese cedar pollinosis in the last pollen scattering season and whose Japanese cedar pollen-specific IgE levels are positive. | |||
| Key exclusion criteria | 1)Those who has allergy to the test beverage and citrus
2)Pregnant woman and those at risk of pregnancy 3)Woman who are planning pregnancy 4)Lactating woman 5)The subject who are judged inappropriate for the study by the doctor |
|||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Shuichi Suzuki |
| Organization | National Hospital Organization
Shimoshizu National Hospital |
| Division name | Department of Pediatrics |
| Address | 934-5,Shikawatashi,Yotsukaido,Chiba |
| TEL | 043-422-2511 |
| 214sy01@hosp.go.jp | |
| Public contact | |
| Name of contact person | Shuichi Suzuki |
| Organization | National Hospital Organization Shimoshizu National Hospital |
| Division name | Department of Pediatrics |
| Address | 934-5,Shikawatashi,Yotsukaido,Chiba |
| TEL | 043-422-2511 |
| Homepage URL | |
| 214sy01@hosp.go.jp | |
| Sponsor | |
| Institute | National Hospital Organization Shimoshizu National Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yakult Honsha Co.,Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029808 |